Origin of CD8+ Effector and Memory T Cell Subsets.

Origin of CD8+ Effector and Memory T Cell Subsets. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Origin of CD8+ Effector and Memory T Cell Subsets. Abstract Text:

Christian Stemberger,Michael Neuenhahn,Veit R Buchholz,Dirk H Busch,Christian Stemberger,Michael Neuenhahn,Veit R Buchholz,Dirk H Busch,Christian Stemberger,Michael Neuenhahn,Veit R Buchholz,Dirk H Busch,

It is well accepted that CD8+ T cells play a pivotal role in providing protection against infection with intracellular pathogens and some tumors. In many cases protective immunity is maintained for long periods of time (immunological memory). Over the past years, it has become evident that in order to fulfill these multiple tasks, distinct subsets of effector and memory T cells have to be generated. Until today, however, little is known about the underlying mechanisms of subset differentiation and the timing of lineage fate decisions. In this context, it is of special importance to determine at which level of clonal expansion functional and phenotypical heterogeneity is achieved. Different models for T cell subset diversification have been proposed; these differ mainly in the time point during priming and clonal expansion (prior, during, or beyond the first cell division) when differentiation programs are induced. Recently developed single-cell adoptive transfer technology has allowed us to demonstrate that individual precursor cell still bears the full plasticity to develop into a plethora different T cell subsets. This observation targets the shaping of T cell subset differentiation towards factors that are still operative beyond the first cell division. These findings have important implications for vaccine development, as the modulation of differentiation patterns towards distinct subsets could become a powerful strategy to enhance the efficacy and quality of vaccines.

Origin of CD8+ Effector and Memory T Cell Subsets. Publishing Authors By Initials

C Stemberger,M Neuenhahn,VR Buchholz,DH Busch,C Stemberger,M Neuenhahn,VR Buchholz,DH Busch,C Stemberger,M Neuenhahn,VR Buchholz,DH Busch,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Origin of CD8+ Effector and Memory T Cell Subsets. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Cellular & molecular immunology

VOLUME: 4

Page Numbers: 399-405

Journal Abbreviation: Cell. Mol. Immunol.

ISSN: 1672-7681

DAY: 31

MONTH: Dec

YEAR: 2007

Origin of CD8+ Effector and Memory T Cell Subsets. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101242872

Origin of CD8+ Effector and Memory T Cell Subsets. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Origin of CD8+ Effector and Memory T Cell Subsets. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Origin of CD8+ Effector and Memory T Cell Subsets.

AFFILIATION: Institute for Medical Microbiology, Immunology and Hygiene, Technical University Munich, Munich, Germany.

Country: China

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Cell Mol Immunol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Origin of CD8+ Effector and Memory T Cell Subsets Related Publications

• Antibodies to a novel antigen in acute hepatitis C virus infections.
• Defining correlates of T cell protection against infection.
• Determination of the enantiomeric composition of guest molecules by chemometric analysis of the UV-visible spectra of cyclodextrin guest-host complexes.
• Do state parity laws reduce the financial burden on families of children with mental health care needs?
• Effect of photosensitizer dose on fluence rate responses to photodynamic therapy.
• Enhanced ascertainment of microchimerism with real-time quantitative polymerase chain reaction amplification of insertion-deletion polymorphisms.
• Improving survival in acute lung injury: is there a role for treatment bundles?
• Inhalation of the ETA receptor antagonist LU-135252 selectively attenuates hypoxic pulmonary vasoconstriction.
• Leukoreduction of blood transfusions does not diminish transfusion-associated microchimerism in trauma patients.
• Local physiological changes during photodynamic therapy.
• Off-label use of exenatide for the management of insulin-resistant type 1 diabetes mellitus in an obese patient with human immunodeficiency virus infection.
• Olefin oxygenation by the hydroperoxide adduct of a nonheme manganese(IV) complex: epoxidations by a metallo-peracid produces gentle selective oxidations.
• One target-multiple indications: a call for an integrated common mechanisms strategy.
• Origin of CD8+ Effector and Memory T Cell Subsets.
• Persistence of West Nile virus-specific antibodies in viremic blood donors.
• Photofrin uptake in the tumor and normal tissues of patients receiving intraperitoneal photodynamic therapy.
• Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay.
• Reply.
• Testing strategy to identify cases of acute hepatitis C virus (HCV) infection and to project HCV incidence rates.
• The course of hepatitis C viraemia in transfusion recipients prior to availability of antiviral therapy.
• The neuronal dynamics underlying cognitive flexibility in set shifting tasks.
• The utility of oral diabetes medications in type 2 diabetes of the young.
• Transfusion-associated microchimerism.
• Transfusion-associated microchimerism: a new complication of blood transfusions in severely injured patients.
• Unique functions of splenic CD8alpha+ dendritic cells during infection with intracellular pathogens.
• [Female genital actinomycosis]
• [In Process Citation]
• [Prediction of spontaneous abortion by vaginal cytologic smears (author's transl)i1]
• [Problems of corticoid therapy in pregnancy]
• [The effects of metacresol sulfonic acid on defects and inflammations of the genital mucosa.]